Guest Editorial by Ellen Troyer, MT, MA CEO, Biosyntrx The Affordable Care Act (ACA) doesn’t pay for Medicare and Medicaid routine eye exams for disease prevention but it does cover diagnosed disease identified in self-pay routine eye exams. This leaves an ever-growing segment of the adult US population with limited access to eye care professionals, [Read More]
Category: Latest News
Driving Still Possible For Some With Low Vision
Low vision doesn’t have to mean losing the privilege of driving a car. That’s the position of the International Academy of Low Vision Specialists (IALVS), an organization committed to helping people realize there is “life after vision loss.” As part of fulfilling that mission, IALVS provides information on Department of Motor Vehicle (DMV) vision requirements in all 50 states, [Read More]
Top 10 Misconceptions About Blindness
Pop quiz from Orcam . . . You’re at a dinner party and your host introduces you to one of the other guests in attendance. The other guest is holding a white cane and wearing sunglasses so you come to the conclusion that they are blind. What do you do? A. Begin conversing with the [Read More]
Trash-Collecting Cells May Accelerate Retinitis Pigmentosa
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study [Read More]
Cheaper Substitute for Lucentis Developed in India
Intas Pharmaceuticals, a company based in India, has launched RAZUMAB™, an anti-VEGF drug that is “biosimilar” to Lucentis. This means that RAZUMAB has a synthesized chemical structure that can substitute for, but not duplicate, Lucentis. To make biosimilarity possible, scientists must show that the new product is highly similar and have no significant differences from [Read More]